Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge

Journal of Trauma and Acute Care Surgery

Volumn 74, Issue 2, 2013, Pages 387-395

  Wafaisade, Arasch ^a   Lefering, Rolf ^a   Maegele, Marc ^a   Brockamp, Thomas ^a   Mutschler, Manuel ^a   Lendemans, Sven ^b   Banerjee, Marc ^a   Bouillon, Bertil ^a   Probst, Christian ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Coagulopathy; Fibrinogen; Hemorrhage; Multiple trauma; Transfusion

Indexed keywords

FIBRINOGEN CONCENTRATE;

ADOLESCENT; ADULT; AGED; ALKALOSIS; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; EXSANGUINATION; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; SURVIVAL; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM;

ADULT; EXSANGUINATION; FEMALE; FIBRINOGEN; HEMOSTATICS; HOSPITAL MORTALITY; HUMANS; MALE; SURVIVAL ANALYSIS; TIME FACTORS; WOUNDS AND INJURIES;

EID: 84875234519     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31827e2410     Document Type: Article

References (39)

1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60:S3-S11.
2. Wafaisade A, Wutzler S, Lefering R, Tjardes T, Banerjee M, Paffrath T, Bouillon B, Maegele M. Drivers of acute coagulopathy after severe trauma: a multivariate analysis of 1987 patients. Emerg Med J. 2010;27:934-939.
3. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, Simanski C, Neugebauer E, Bouillon B. Early coagulopathyinmultipleinjury:ananalysis from the German Trauma Registry on 8724 patients. Injury. 2007;38:298-304.
4. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54:1127-1130.
5. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805-813.
6. Duchesne JC, Hunt JP, Wahl G, Marr AB, Wang Y, Weintraub SE, Wright MJO, McSwain NE. Reviewofcurrent blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma. 2008;65:272-278.
7. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248: 447-458.
8. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registryof the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang. 2008;95:112-119.
9. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14:R52.
10. Schöchl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, Solomon C. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care. 2011;15:R265.
11. Callum JL, Karkouti K, Lin Y. Cryoprecipitate: the current state of knowledge. Transfus Medicine Rev. 2009;23:177-188.
12. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, Hess JR, Dubick MA, Simon CD, Beekley AC, et al. The ratio of fi-brinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;64:S79-S85.
13. Sørensen B, Larsen OH, Rea CJ, Tang M, Foley JH, Fenger-Eriksen C. Fibrinogen as a hemostatic agent. Semin Thromb Hemost. 2012;38:268-273.
14. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10:1342-1351.
15. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration offibrinogen concentrate and prothrombincomplex concentrate. Crit Care. 2010;14:R55.
16. Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrateYbased therapy versus standard fresh frozen plasmaYbased therapy. Crit Care. 2011;15:R83.
17. Nienaber U, Innerhofer P, Westermann I, Schöchl H, Attal R, Breitkopf R, Maegele M. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury. 2011;42:697-701.
18. Trauma Register of the German Society of Trauma Surgery. "Scoring" study committee of the German Society of Trauma Surgery. Unfallchirurg. 1994;97:230-237.
19. Ruchholtz S, Lefering R, Paffrath T, Oestern HJ, Neugebauer E, Nast-Kolb D, Pape HC, Bouillon B. Reduction in mortality of severely injured patients in Germany. Dtsch Arztebl Int. 2008;105:225-231. Available at: www.traumaregister. de. Accessed August 20, 2012.
20. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
21. Association for the Advancement of Automotive Medicine. The Abbreviated Injury Scale (AIS) 2005 Revision. Barrington, IL: Association for the Advancement of Automotive Medicine; 2005.
22. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26:1793-1800.
23. Bone RC. Let's agree on terminology: definitions of sepsis. Crit Care Med. 1991;19:973-976.
24. Wagner C, Dati F. Thromboplastinzeit. In: Thomas L, ed. Labor und Diagnose. Frankfurt, Germany: TH-Books Verlagsgesellschaft; 2000:613-616.
25. Yücel N, Lefering R, Maegele M, Vorweg M, Tjardes T, Ruchholtz S, Neugebauer EAM, Wappler F, Bouillon B, Rixen D. Trauma Associated Severe Hemorrhage (TASH) Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma. 2006;60:1228-1237.
26. Maegele M, Lefering R, Wafaisade A, Theodorou P, Wutzler S, Fischer P, Bouillon B, Paffrath T. Revalidation and update of the TASH Score: a scoring system to predict the probability for massive transfusion as a surrogate for life-threatening haemorrhage after severe injury. Vox Sang. 2011;100:231-238.
27. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaest. 2008;101:769-773.
28. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schöchl H, Wade CE, Holcomb JB, Matijevic N. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012;73:365-370.
29. Coats TJ, Brazil E, Heron M, MacCallum PK. Impairment of coagulation by commonly used resuscitation fluids in human volunteers. Emerg Med J. 2006;23:846-849.
30. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernández- Mondéjar E, Gordini G, Stahel PF, Hunt BJ, Komadina R, Neugebauer E, et al. Management of bleeding following major trauma: a European guideline. Crit Care. 2007;11:R17.
31. Wafaisade A, Lefering R, Maegele M, Lendemans S, Flohé S, Hussmann B, Defosse JM, Probst C, Paffrath T, Bouillon B; Trauma Registry of DGU. Coagulation management of bleeding trauma patientsis changing in German traumacenters:ananalysis fromthetrauma registryoftheGerman Societyfor Trauma Surgery. J Trauma Acute Care Surg. 2012;72:936-942.
32. Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009;102:137-144.
33. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost. 2009;7:795-802.
34. Meyer MA, Ostrowski SR, Windeløv NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang. 2011;101:185-190.
35. Danés AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang. 2008;94:221-226.
36. Weiss G, Lison S, Glaser M, Herberger S, Johanning K, Strasser T, Huber T, Spannagl M, Heindl B. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register. Blood Coagul Fibrinolysis. 2011;22:727-734.
37. Holcomb JB, Weiskopf R, Champion H, Gould SA, Sauer RM, Brasel K, Bochicchio G, Bulger E, Cotton BA, Davis D, et al. Challenges to effective research in acute trauma resuscitation: consent and endpoints. Shock. 2011;35:107-113.
38. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34:43-62.
39. CRASH-2 Trial Collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23-32.